Project Description

BACK TO OVERVIEW 2016

Inositec AG
Technoparkstrasse
8005 Zurich
+41 44 271 07 55
info@inositec.com
www.inositec.com

NEW THERAPIES VIA NATURAL MOLECULES

Inositec from Zurich is developing novel therapeutics from its proprietary platform of small molecules. The lead product is a novel treatment for a widespread colon infection and the second is an inhibitor of vascular calcifications.

Additional Teammembers

Prof. Bastien Castagner, co-founder; Prof. Jean-Christophe Leroux, co-founder